Aldactone: Effective Potassium-Sparing Diuretic Therapy
Aldactone
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | 1.29 $ | 77.22 $ (0%) | 🛒 Add to cart |
| 90 | 1.21 $ | 115.83 $ 108.81 $ (6%) | 🛒 Add to cart |
| 120 | 1.18 $ | 154.44 $ 141.57 $ (8%) | 🛒 Add to cart |
| 180 | 1.15 $ | 231.66 $ 207.09 $ (11%) | 🛒 Add to cart |
| 270 | 1.12 $ | 347.49 $ 303.03 $ (13%) | 🛒 Add to cart |
| 360 | 1.12 $
Best per pill | 463.32 $ 403.65 $ (13%) | 🛒 Add to cart |
Aldactone (spironolactone) is a prescription medication belonging to the class of potassium-sparing diuretics. It functions by blocking the effects of aldosterone, a hormone that regulates salt and water balance in the body. This action promotes the excretion of sodium and water while conserving potassium, making it a valuable therapeutic agent for managing various conditions related to fluid retention and hormonal imbalances. Its dual mechanism offers both diuretic and anti-androgenic properties, supporting its use in diverse clinical scenarios under medical supervision.
Features
- Active ingredient: Spironolactone
- Drug class: Potassium-sparing diuretic, aldosterone antagonist
- Available in oral tablet formulations: 25 mg, 50 mg, 100 mg strengths
- Prescription-only medication
- Typically administered once or twice daily, as directed
- Manufactured under strict pharmaceutical quality standards
Benefits
- Effectively reduces edema and fluid retention associated with heart failure, liver cirrhosis, and nephrotic syndrome
- Helps manage hypertension by promoting sodium excretion and reducing blood volume
- Used in the treatment of primary hyperaldosteronism to counteract excessive aldosterone production
- May improve outcomes in heart failure by counteracting harmful aldosterone effects on the cardiovascular system
- Off-label uses include management of hormonal acne and hirsutism in women due to its anti-androgenic properties
- Potassium-sparing action helps prevent hypokalemia, a common side effect of other diuretics
Common use
Aldactone is commonly prescribed for the management of conditions where fluid retention is a significant concern. In heart failure, it is used to reduce edema and improve symptoms like shortness of breath and swelling. For patients with liver cirrhosis and ascites, it helps control abdominal fluid accumulation. It is also indicated for the treatment of essential hypertension, often in combination with other antihypertensive agents. In endocrinology, it serves as a key therapy for primary hyperaldosteronism (Conn’s syndrome). Dermatologists may prescribe it off-label for androgen-dependent conditions such as acne vulgaris and hirsutism in women, leveraging its anti-androgenic effects.
Dosage and direction
Dosage of Aldactone must be individualized based on the patient’s condition, renal function, and electrolyte levels. For edema in adults, the typical starting dose is 50 to 100 mg daily in single or divided doses. For hypertension, doses usually range from 50 to 100 mg daily. In heart failure, evidence-based guidelines often recommend 25 mg once daily, with titration based on tolerance and potassium levels. For primary hyperaldosteronism, doses may be higher, up to 400 mg daily in divided doses. Tablets should be taken with food to enhance absorption and reduce gastrointestinal upset. Regular monitoring of serum potassium and renal function is essential during therapy.
Precautions
Patients taking Aldactone should have baseline and periodic measurements of electrolytes, particularly potassium and sodium, and renal function. Use with caution in patients with renal impairment, as reduced clearance may increase the risk of hyperkalemia. Avoid in patients with acute renal insufficiency or significant impairment. Caution is advised in elderly patients, who may be more susceptible to electrolyte disturbances and dehydration. Patients should be advised to avoid high-potassium diets or potassium supplements unless directed by a physician. Aldactone may cause dizziness or lightheadedness, especially during the initial therapy phase; patients should avoid driving or operating machinery until they know how the medication affects them.
Contraindications
Aldactone is contraindicated in patients with hyperkalemia, acute renal insufficiency, significant renal impairment (e.g., anuria), or Addison’s disease. It should not be used in patients with known hypersensitivity to spironolactone or any component of the formulation. Concomitant use with eplerenone or other potassium-sparing diuretics is contraindicated due to additive hyperkalemia risk. Avoid use in pregnancy due to potential anti-androgenic effects on the developing fetus. It is also contraindicated in patients with severe hepatic impairment where electrolyte imbalances could precipitate hepatic encephalopathy.
Possible side effect
Common side effects may include dizziness, headache, gastrointestinal disturbances such as nausea, vomiting, diarrhea, or cramping. Electrolyte imbalances like hyperkalemia (elevated potassium) or hyponatremia (low sodium) may occur, particularly in susceptible individuals. Gynecomastia (breast enlargement or tenderness) may develop in men, which is often dose-dependent and reversible upon discontinuation. Menstrual irregularities, impotence, or decreased libido may occur. Skin rash, photosensitivity, or hair loss has been reported rarely. More serious but rare side effects include severe hyperkalemia, which can lead to cardiac arrhythmias, or hepatotoxicity.
Drug interaction
Aldactone may interact with several medications, necessitating careful review of the patient’s drug regimen. Concomitant use with ACE inhibitors, ARBs, or direct renin inhibitors increases the risk of hyperkalemia. NSAIDs may reduce diuretic and antihypertensive efficacy and increase nephrotoxicity risk. Use with other potassium-sparing agents or potassium supplements is generally avoided. Aldactone may potentiate the effects of other antihypertensives or diuretics, requiring dose adjustment. It may interfere with digoxin assays, leading to falsely elevated levels. Corticosteroids may enhance potassium excretion, somewhat counteracting Aldactone’s effects.
Missed dose
If a dose of Aldactone is missed, it should be taken as soon as remembered on the same day. However, if it is near the time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended, as it may increase the risk of side effects such as electrolyte imbalances. Patients should maintain a consistent dosing routine and may benefit from setting reminders to improve adherence.
Overdose
Overdose of Aldactone may manifest primarily as electrolyte disturbances, particularly hyperkalemia, which can be life-threatening. Symptoms of hyperkalemia include muscle weakness, irregular heartbeat, nausea, and paresthesia. In cases of suspected overdose, immediate medical attention is crucial. Treatment is supportive and may include discontinuation of Aldactone, ECG monitoring, and measures to reduce serum potassium, such as administration of calcium gluconeate, insulin with glucose, or sodium polystyrene sulfonate. Hemodialysis may be considered in severe cases, though spironolactone and its metabolites are not efficiently removed by dialysis.
Storage
Aldactone tablets should be stored at room temperature, between 15°C to 30°C (59°F to 86°F), in a tightly closed container, and protected from light and moisture. Keep out of reach of children and pets. Do not store in bathrooms or other areas prone to humidity. Discard any unused medication after the expiration date or as advised by a pharmacist, following local regulations for medication disposal to ensure environmental safety.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or stopping any medication. Individual patient needs and responses may vary. Do not disregard or delay seeking medical advice based on content provided here. The manufacturer and publisher are not liable for any adverse effects or outcomes resulting from the use or misuse of this information.
Reviews
Clinical studies and patient reports generally reflect positive experiences with Aldactone when used appropriately under medical supervision. Many patients with heart failure or edema report significant improvement in symptoms such as reduced swelling and shortness of breath. In dermatological use, patients often note improvement in acne and hirsutism over several months. Some users mention side effects like dizziness or menstrual changes, which often subside with time or dose adjustment. Overall, it is regarded as an effective and well-tolerated therapy for indicated conditions when monitored properly.